Fulgent Genetics Net Profit Margin 2015-2025 | FLGT
Fulgent Genetics net profit margin from 2015 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Fulgent Genetics Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-09-30 | $0.32B | $-0.04B | -13.97% |
| 2025-06-30 | $0.30B | $-0.05B | -17.16% |
| 2025-03-31 | $0.29B | $-0.04B | -14.38% |
| 2024-12-31 | $0.28B | $-0.04B | -15.19% |
| 2024-09-30 | $0.28B | $-0.17B | -59.35% |
| 2024-06-30 | $0.29B | $-0.16B | -56.01% |
| 2024-03-31 | $0.29B | $-0.17B | -57.29% |
| 2023-12-31 | $0.29B | $-0.17B | -57.59% |
| 2023-09-30 | $0.29B | $-0.06B | -21.95% |
| 2023-06-30 | $0.31B | $-0.05B | -15.58% |
| 2023-03-31 | $0.37B | $-0.03B | -6.85% |
| 2022-12-31 | $0.62B | $0.14B | 23.26% |
| 2022-09-30 | $0.80B | $0.27B | 33.87% |
| 2022-06-30 | $0.93B | $0.39B | 42.49% |
| 2022-03-31 | $0.95B | $0.46B | 48.32% |
| 2021-12-31 | $0.99B | $0.51B | 51.16% |
| 2021-09-30 | $1.04B | $0.57B | 55.02% |
| 2021-06-30 | $0.91B | $0.49B | 54.29% |
| 2021-03-31 | $0.77B | $0.42B | 53.95% |
| 2020-12-31 | $0.42B | $0.21B | 50.71% |
| 2020-09-30 | $0.14B | $0.05B | 35.56% |
| 2020-06-30 | $0.04B | $0.00B | 4.65% |
| 2020-03-31 | $0.03B | $0.00B | -2.94% |
| 2019-12-31 | $0.03B | $0.00B | -3.23% |
| 2019-09-30 | $0.03B | $0.00B | -10.34% |
| 2019-06-30 | $0.03B | $-0.01B | -20.00% |
| 2019-03-31 | $0.02B | $-0.01B | -27.27% |
| 2018-12-31 | $0.02B | $-0.01B | -27.27% |
| 2018-09-30 | $0.02B | $-0.01B | -30.00% |
| 2018-06-30 | $0.02B | $-0.01B | -31.58% |
| 2018-03-31 | $0.02B | $-0.01B | -26.32% |
| 2017-12-31 | $0.02B | $0.00B | -15.79% |
| 2017-09-30 | $0.02B | 0 | 0.00% |
| 2017-06-30 | $0.02B | 0 | 0.00% |
| 2017-03-31 | $0.02B | $-0.01B | -25.00% |
| 2016-12-31 | $0.02B | $-0.01B | -33.33% |
| 2016-06-30 | $0.01B | $-0.01B | -60.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.891B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.404B | 55.40 |
| Tempus AI (TEM) | United States | $11.811B | 0.00 |
| Doximity (DOCS) | United States | $8.862B | 36.49 |
| Hims & Hers Health (HIMS) | United States | $8.100B | 65.89 |
| IRhythm Technologies (IRTC) | United States | $5.397B | 0.00 |
| Hinge Health (HNGE) | United States | $3.215B | 0.00 |
| Privia Health (PRVA) | United States | $2.856B | 178.62 |
| Inspire Medical Systems (INSP) | United States | $2.466B | 40.80 |
| Heartflow (HTFL) | United States | $2.248B | 0.00 |
| 10x Genomics (TXG) | United States | $1.987B | 0.00 |
| Enovis (ENOV) | United States | $1.618B | 8.50 |
| Omnicell (OMCL) | United States | $1.534B | 31.37 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Schrodinger (SDGR) | United States | $1.286B | 0.00 |
| Phreesia (PHR) | United States | $1.234B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.214B | 0.00 |
| Claritev (CTEV) | United States | $0.630B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 106.00 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.465B | 0.00 |
| Evolent Health (EVH) | United States | $0.432B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.327B | 0.00 |
| TruBridge (TBRG) | United States | $0.308B | 14.15 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.274B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.248B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.158B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.132B | 7.23 |
| EUDA Health Holdings (EUDA) | Singapore | $0.103B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| Pulmonx (LUNG) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |